Cargando…

The Analysis of bcl-2 in Association with p53 and Ki-67 in Triple Negative Breast Cancer and Other Molecular Subtypes in Ghana

BACKGROUND: Little is known about the role of apoptosis in the tumorigenesis and prognosis of breast cancer in Ghana. Chemotherapeutic drug efficacy partially relates to apoptosis induction, rendering it a vital target in cancer therapy with unique biomarker opportunities that have not been exploite...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ameh-Mensah, Charity, Duduyemi, Babatunde Moses, Bedu-Addo, Kweku, Atta Manu, Elijah, Opoku, Francis, Titiloye, Nicholas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8195641/ https://www.ncbi.nlm.nih.gov/pubmed/34188682 http://dx.doi.org/10.1155/2021/7054134

Ejemplares similares

Expression profile of tumour suppressor protein p53 and its regulator MDM2 in a cohort of breast cancer patients in a Tertiary Hospital in Ghana
por: Opoku, Francis, et al.
Publicado: (2021)

Expression of Tumour-Associated MUC1 Is a Poor Prognostic Marker in Breast Cancer in Kumasi, Ghana
por: Atta Manu, E., et al.
Publicado: (2020)

Skin and Soft Tissue Lesions in a District Hospital in Central Nigeria: A Histopathological Study
por: Duduyemi, Babatunde M., et al.
Publicado: (2019)

Prognostic and predictive value of Ki-67 in triple-negative breast cancer
por: Wang, Wei, et al.
Publicado: (2016)

The prognostic and predictive potential of Ki-67 in triple-negative breast cancer
por: Zhu, Xiuzhi, et al.
Publicado: (2020)

Predictive Significance of p53, Ki-67, and Bcl-2 Expression for Pathologic Complete Response after Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer
por: Kim, Taeryung, et al.
Publicado: (2015)

Ki-67 gene expression
por: Uxa, Sigrid, et al.
Publicado: (2021)

Molecular subtyping of ependymoma and prognostic impact of Ki-67
por: Lim, Ka Young, et al.
Publicado: (2021)

Is the AKOBEN programme the panacea to gold mining related environmental degradation in Ghana? An integrated analysis of the AKOBEN programme
por: Bedu-Addo, Kenneth
Publicado: (2022)

Can p53, Ki-67 and bcl-2 predict biochemical failure after radical prostatectomy?
por: Baseskioglu, B., et al.
Publicado: (2010)

The relation of pericoronal third molar follicle dimension and bcl-2/ki-67 expression: An immunohistochemical study
por: Razavi, Seyed Mohammad, et al.
Publicado: (2012)

Breastfeeding and Immunohistochemical Expression of ki-67, p53 and BCL2 in Infiltrating Lobular Breast Carcinoma
por: Gonzalez-Sistal, Angel, et al.
Publicado: (2016)

To Ki or Not to Ki: Re-Evaluating the Use and Potentials of Ki-67 for T Cell Analysis
por: Di Rosa, Francesca, et al.
Publicado: (2021)

Ki67 as a predictor of poor prognosis in patients with triple-negative breast cancer
por: LI, HAITAO, et al.
Publicado: (2015)

P53 and Ki-67 as prognostic markers in triple-negative breast cancer patients
por: Pan, Yunbao, et al.
Publicado: (2017)

KI-67 LI Expression in Triple-Negative Breast Cancer Patients and Its Significance
por: Arafah, Maria A, et al.
Publicado: (2021)

Corrigendum: To Ki or Not to Ki: Re-Evaluating the Use and Potentials of Ki-67 for T Cell Analysis
por: Di Rosa, Francesca, et al.
Publicado: (2021)

A comparative immunohistochemical study of Ki-67 and Bcl-2 expression in solid ameloblastoma and adenomatoid odontogenic tumor
por: Razavi, Sayed Mohammad, et al.
Publicado: (2012)

Prognostic Value of Immunohistochemical Staining of p53, bcl-2, and Ki-67 in Small Cell Lung Cancer
por: Paik, Kwang Hyun, et al.
Publicado: (2006)

PCNA, Ki-67, p53, bcl-2 and Prognosis in Intraoral Squamous Cell Carcinoma of the Head and Neck
por: Nylander, Karin, et al.
Publicado: (1997)

The intrinsically disorderly story of Ki-67
por: Remnant, Lucy, et al.
Publicado: (2021)

Ki-67 can be used for further classification of triple negative breast cancer into two subtypes with different response and prognosis
por: Keam, Bhumsuk, et al.
Publicado: (2011)

Ki-67, p53 and BCL-2 Expressions and their Association with Clinical Histopathology of Breast Cancer among Women in Tanzania
por: Mansouri, Hidaya, et al.
Publicado: (2019)

A 6-Year Retrospective Review of Histopathological Pattern of Surgical Biopsies in Children with Refractory Constipation in a Tertiary Hospital in Ghana
por: Yifieyeh, Abiboye C., et al.
Publicado: (2018)

Proliferative activity in human breast cancer: Ki-67 automated evaluation and the influence of different Ki-67 equivalent antibodies
por: Fasanella, S, et al.
Publicado: (2011)

Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group
por: Nielsen, Torsten O, et al.
Publicado: (2020)

New insights into the prognostic value of Ki-67 labeling index in patients with triple-negative breast cancer
por: Hao, Shuang, et al.
Publicado: (2016)

Prognostic Value of Ki-67 in Patients With Resected Triple-Negative Breast Cancer: A Meta-Analysis
por: Wu, Qiang, et al.
Publicado: (2019)

The prognostic relevance of p53 and Ki-67 to chemotherapy sensitivity and prognosis in triple-negative breast cancer
por: Zhang, Guojing, et al.
Publicado: (2021)

Immunolocalization of Ki-67 in different periodontal conditions
por: Preethi, Penubolu Lakshmi, et al.
Publicado: (2014)

Quantum Dots-Based Quantitative and In Situ Multiple Imaging on Ki67 and Cytokeratin to Improve Ki67 Assessment in Breast Cancer
por: Yuan, Jing Ping, et al.
Publicado: (2015)

ki67 nuclei detection and ki67-index estimation: a novel automatic approach based on human vision modeling
por: Barricelli, Barbara Rita, et al.
Publicado: (2019)

Independent Clinical Validation of the Automated Ki67 Scoring Guideline from the International Ki67 in Breast Cancer Working Group
por: Boyaci, Ceren, et al.
Publicado: (2021)

Low correlation between Ki67 assessed by qRT-PCR in Oncotype Dx score and Ki67 assessed by Immunohistochemistry
por: Selmani, Zohair, et al.
Publicado: (2022)

Ki-67 and breast cancer prognosis: does it matter if Ki-67 level is examined using preoperative biopsy or postoperative specimen?
por: Choi, Soon Bo, et al.
Publicado: (2022)

Malformations: A 5-Year Review of the Presentation and Management in a Teaching Hospital in Ghana
por: Yifieyeh, Abiboye C., et al.
Publicado: (2018)

Dimensional Analysis of CD44(High) CD24(Low) and Ki67 in Triple Negative Breast Cancer
por: Tan, Betty, et al.
Publicado: (2019)

A comparative study between Ki67 positive versus Ki67 negative females with breast cancer: Cross sectional study
por: Bahaddin, Mowafak Masoud
Publicado: (2020)

The role of Ki-67 in the proliferation and prognosis of breast cancer molecular classification subtypes
por: Stathopoulos, George P., et al.
Publicado: (2014)

Ki-67 as a prognostic marker according to breast cancer molecular subtype
por: Soliman, Nahed A., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_mcbfniump3dfps7nh7ek37iu0g